A Molecule Poised to Revolutionize Ocular Surface Care

An expanding pool of clinical data is supporting the benefits and sustained efficacy of therapies that include bioprotectants such as trehalose to protect cells against hyperosmolarity and promote exit of the vicious cycle of dry eye disease (DED) physiopathology.

As such, lubricant eye drops enhanced with trehalose can provide patients with a new, successful way to rehabilitate the tear film in Ocular Surface Disease and DED.